ARWR vs BIIB: Which Stock is Better?
Side-by-side comparison of Arrowhead Pharmaceuticals Inc and Biogen Inc in 2026
ARWR
Arrowhead Pharmaceuticals Inc
$70.53
BIIB
Biogen Inc
$194.38
Key Metrics Comparison
| Metric | ARWR | BIIB | Winner |
|---|---|---|---|
| Market Cap | $9.82B | $26.91B | BIIB |
| P/E Ratio | 43.83 | 20.89 | BIIB |
| EPS (TTM) | $1.60 | $8.78 | BIIB |
| Revenue Growth | 104.6% | -0.1% | ARWR |
| Gross Margin | 100.0% | 78.9% | ARWR |
Analyze ARWR
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ARWR or BIIB a better investment?
Comparing ARWR and BIIB: Arrowhead Pharmaceuticals Inc has a market cap of $9.82B while Biogen Inc has $26.91B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ARWR and BIIB?
ARWR (Arrowhead Pharmaceuticals Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ARWR or BIIB?
Based on P/E ratios, BIIB trades at a lower multiple (20.9x vs 43.8x).
Which is growing faster: ARWR or BIIB?
ARWR has higher revenue growth at 104.6% vs -0.1% for BIIB.
Which company is more profitable: ARWR or BIIB?
Arrowhead Pharmaceuticals Inc (ARWR) has higher gross margins at 100.0% compared to 78.9% for BIIB.
Which is the larger company: ARWR or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $26.91B compared to $9.82B for ARWR.
Should I buy ARWR or BIIB in 2026?
Both ARWR and BIIB have investment merit. ARWR trades at $70.53 while BIIB trades at $194.38. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ARWR and BIIB stock?
Key differences: Market Cap ($9.82B vs $26.91B), P/E Ratio (43.8x vs 20.9x), Revenue Growth (104.6% vs -0.1%), Gross Margin (100.0% vs 78.9%).